Elemental Biologics
PrivateLast Round
Seed
Apr 1, 2026
Company Overview
Elemental Biologics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in April 2026.
Elemental Biologics is a biotechnology company developing monoclonal antibody therapies for immune-driven diseases including autoimmune, inflammatory, and fibrotic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elemental Biologics Comparables
Compare Elemental Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneWalk Therapeutics | 84% | |
| Re-Aim Therapeutics | 83% | |
| Antharis Therapeutics, Inc. | 82% |
For institutional investors. Book with your work email.
Elemental Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Elemental Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yazbeck & Co. | Seed |
Elemental Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elemental Biologics's valuation, stock price, and market status.
Is Elemental Biologics a public or private company?
Elemental Biologics is a private company.
What is the current stock price of Elemental Biologics?
Elemental Biologics is a private company, so its shares have no public market price. Caplight tracks Elemental Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elemental Biologics worth (valuation)?
Valuation information for Elemental Biologics is not publicly available.
Can I buy Elemental Biologics stock?
Elemental Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elemental Biologics's last funding round?
Elemental Biologics's most recent funding round was Seed on April 1, 2026.
Who are the main investors in Elemental Biologics?
Key investors in Elemental Biologics include Yazbeck & Co..
Will Elemental Biologics IPO soon?
No public IPO plans have been announced for Elemental Biologics.
How can I track Elemental Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Elemental Biologics's shares on secondary markets.